Results showed that the severity of arthritis was lower in the etoposide treated mice as monitored by the overall arthritis index, histopathological picture and decreased levels of pro-inflammatory cytokines, lower levels of reactive oxygen species and reduced levels of MMP-2. This evidence concerns the gene MMP2 and arthritic joint disease.